Glutamine depletion and glucose depletion trigger growth inhibition via distinctive gene expression reprogramming

Cell Cycle

Volumn 11, Issue 19, 2012, Pages 3679-3690

  Qie, Shuo ^a,b   Liang, Dongming ^a   Yin, Chengqian ^a   Gu, Weiting ^c,d   Meng, Meng ^a   Wang, Chenguang ^c,d   Sang, Nianli ^a,b  

^a DREXEL UNIVERSITY   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d SHANDONG UNIVERSITY   (China)

Author keywords

ATF4; ATF6; ER stress; Glucose depletion; Glutamine depletion; Metabolism; XBP1

Indexed keywords

GLUCOSE; GLUTAMINE; HYPOXIA INDUCIBLE FACTOR; MESSENGER RNA; RNA;

ARTICLE; CELL CYCLE; CELL GROWTH; CELL METABOLISM; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION; GENE SEQUENCE; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; HYPOXIA; ISCHEMIA; NUCLEOTIDE SEQUENCE; NUTRIENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLID TUMOR; UNINDEXED SEQUENCE; WESTERN BLOTTING;

EID: 84867244394     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.21944     Document Type: Article

References (43)

1. Dang CV. Glutaminolysis: supplying carbon or nitrogen or both for cancer cells? Cell Cycle 2010; 9:3884-6; PMID:20948290; http://dx.doi.org/10.4161/cc.9. 19.13302.
2. Dang CV, Hamaker M, Sun P, Le A, Gao P. Therapeutic targeting of cancer cell metabolism. J Mol Med (Berl) 2011; 89:205-12; PMID:21301795; http://dx.doi.org/10.1007/s00109-011-0730-x.
3. Yin C, Qie S, Sang N. Carbon source metabolism and its regulation in cancer cells. Crit Rev Eukaryot Gene Expr 2012; 22:17-35; PMID:22339657; http://dx.doi.org/10.1615/CritRevEukarGeneExpr.v22.i1.20.
4. Liang D, Kong X, Sang N. Effects of histone deacetylase inhibitors on HIF-1. Cell Cycle 2006; 5:2430-5; PMID:17102633; http://dx.doi.org/10.4161/cc.5. 21.3409.
5. Sang N, Fang J, Srinivas V, Leshchinsky I, Caro J. Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP. Mol Cell Biol 2002; 22:2984-92; PMID:11940656; http://dx.doi.org/10. 1128/MCB.22.9.2984-2992.2002.
6. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013.
7. Bayley JP, Devilee P. The Warburg effect in 2012. Curr Opin Oncol 2012; 24:62-7; PMID:22123234; http://dx.doi.org/10.1097/CCO.0b013e32834deb9e.
8. Levine AJ, Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 2010; 330:1340-4; PMID:21127244; http://dx.doi.org/10.1126/science.1193494.
9. Huang YC, Chang WL, Huang SF, Lin CY, Lin HC, Chang TC. Pachymic acid stimulates glucose uptake through enhanced GLUT4 expression and translocation. Eur J Pharmacol 2010; 648:39-49; PMID:20816811; http://dx.doi.org/10.1016/j. ejphar.2010.08.021.
10. Welsh GI, Hers I, Berwick DC, Dell G, Wherlock M, Birkin R, et al. Role of protein kinase B in insulin-regulated glucose uptake. Biochem Soc Trans 2005; 33:346-9; PMID:15787603; http://dx.doi.org/10.1042/BST0330346.
11. Koppenol WH, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011; 11:325-37; PMID:21508971; http://dx.doi.org/10.1038/nrc3038.
12. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324:1029-33; PMID:19460998; http://dx.doi.org/10.1126/science.1160809.
13. Li A, Fang MD, Song WQ, Chen CB, Qi LW, Wang CG. Gene expression profiles of two intraspecific Larix lines and their reciprocal hybrids. Mol Biol Rep 2012; 39:3773-84; PMID:21750915; http://dx.doi.org/10.1007/s11033-011-1154-y.
14. Meng M, Chen S, Lao T, Liang D, Sang N. Nitrogen anabolism underlies the importance of glutaminolysis in proliferating cells. Cell Cycle 2010; 9:3921-32; PMID:20935507; http://dx.doi.org/10.4161/cc.9.19.13139.
15. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009; 458:762-5; PMID:19219026; http://dx.doi.org/10.1038/nature07823.
16. DeBerardinis RJ, Cheng T. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 2010; 29:313-24; PMID:19881548; http://dx.doi.org/10.1038/onc.2009.358.
17. Dang CV. Therapeutic targeting of Myc-reprogrammed cancer cell metabolism. Cold Spring Harb Symp Quant Biol 2011; 76:369-74; PMID:21960526; http://dx.doi.org/10.1101/sqb.2011.76.011296.
18. Lu X, Kang Y. Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res 2010; 16:5928-35; PMID:20962028.
19. Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 2003; 11:619-33; PMID:12667446; http://dx.doi.org/10. 1016/S1097-2765(03)00105-9.
20. Hao S, Sharp JW, Ross-Inta CM, McDaniel BJ, Anthony TG, Wek RC, et al. Uncharged tRNA and sensing of amino acid deficiency in mammalian piriform cortex. Science 2005; 307:1776-8; PMID:15774759; http://dx.doi.org/10.1126/ science.1104882.
21. Dang Do AN, Kimball SR, Cavener DR, Jefferson LS. eIF2alpha kinases GCN2 and PERK modulate transcription and translation of distinct sets of mRNAs in mouse liver. Physiol Genomics 2009; 38:328-41; PMID:19509078; http://dx.doi.org/10.1152/physiolgenomics.90396.2008.
22. Kroemer G, Mariño G, Levine B. Autophagy and the integrated stress response. Mol Cell 2010; 40:280-93; PMID:20965422; http://dx.doi.org/10.1016/j. molcel.2010.09.023.
23. Ye J, Kumanova M, Hart LS, Sloane K, Zhang H, De Panis DN, et al. The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J 2010; 29:2082-96; PMID:20473272; http://dx.doi.org/10.1038/emboj.2010.81.
24. Kilberg MS, Shan J, Su N. ATF4-dependent transcription mediates signaling of amino acid limitation.Trends Endocrinol Metab 2009; 20:436-43; PMID:19800252; http://dx.doi.org/10.1016/j.tem.2009.05.008.
25. Shan J, Lopez MC, Baker HV, Kilberg MS. Expression profiling after activation of the amino acid deprivation response in HepG2 human hepatoma cells. Physiol Genomics 2010; PMID:20215415; http://dx.doi.org/10.1152/ physiolgenomics.00217.2009.
26. Sikalidis AK, Lee JI, Stipanuk MH. Gene expression and integrated stress response in HepG2/C3A cells cultured in amino acid deficient medium. Amino Acids 2011; 41:159-71; PMID:20361218; http://dx.doi.org/10.1007/s00726-010-0571-x.
27. Lee JI, Dominy JE Jr., Sikalidis AK, Hirschberger LL, Wang W, Stipanuk MH. HepG2/C3A cells respond to cysteine deprivation by induction of the amino acid deprivation/integrated stress response pathway. Physiol Genomics 2008; 33:218-29; PMID:18285520; http://dx.doi.org/10.1152/physiolgenomics.00263.2007.
28. Matsuyama A, Hisaoka M, Nagao Y, Hashimoto H. Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study. Virchows Arch 2011; 458:583-92; PMID:21394649.
29. Yoon SJ, Wills AE, Chuong E, Gupta R, Baker JC. HEB and E2A function as SMAD/FOXH1 cofactors.Genes Dev 2011; 25:1654-61; PMID:21828274; http://dx.doi.org/10.1101/gad.16800511.
30. Moon NS, Rong Zeng W, Premdas P, Santaguida M, Bérubé G, Nepveu A. Expression of N-terminally truncated isoforms of CDP/CUX is increased in human uterine leiomyomas. Int J Cancer 2002; 100:429-32; PMID:12115525.
31. Yu J, Liu P, Cui X, Sui Y, Ji G, Guan R, et al. Identification of novel subregions of LOH in gastric cancer and analysis of the HIC1 and TOB1 tumor suppressor genes in these subregions. Mol Cells 2011; 32:47-55; PMID:21533545; http://dx.doi.org/10.1007/s10059-011-2316-4.
32. Fischer A, Gessler M. Hey genes in cardiovascular development. Trends Cardiovasc Med 2003; 13:221-6; PMID:12922017; http://dx.doi.org/10.1016/S1050- 1738(03)00082-3.
33. Takata T, Ishikawa F. Human Sir2-related protein SIRT1 associates with the bHLH repressors HES1 and HEY2 and is involved in HES1- and HEY2-mediated transcriptional repression. Biochem Biophys Res Commun 2003; 301:250-7; PMID:12535671; http://dx.doi.org/10.1016/S0006-291X(02)03020-6.
34. Swanson KA, Knoepfler PS, Huang K, Kang RS, Cowley SM, Laherty CD, et al. HBP1 and Mad1 repressors bind the Sin3 corepressor PAH2 domain with opposite helical orientations. Nat Struct Mol Biol 2004; 11:738-46; PMID:15235594; http://dx.doi.org/10.1038/nsmb798.
35. Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, Eisenman RN. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 1997; 89:349-56; PMID:9150134; http://dx.doi.org/10.1016/S0092- 8674(00)80215-9.
36. Kode A, Mosialou I, Silva BC, Joshi S, Ferron M, Rached MT, et al. FoxO1 protein cooperates with ATF4 protein in osteoblasts to control glucose homeostasis. J Biol Chem 2012; 287:8757-68; PMID:22298775; http://dx.doi.org/10. 1074/jbc.M111.282897.
37. Meex SJ, van Greevenbroek MM, Ayoubi TA, Vlietinck R, van Vliet-Ostaptchouk JV, Hofker MH, et al. Activating transcription factor 6 polymorphisms and haplotypes are associated with impaired glucose homeostasis and type 2 diabetes in Dutch Caucasians. J Clin Endocrinol Metab 2007; 92:2720-5; PMID:17440018; http://dx.doi.org/10.1210/jc.2006-2280.
38. Ye J, Koumenis C. ATF4, an ER stress and hypoxia-inducible transcription factor and its potential role in hypoxia tolerance and tumorigenesis. Curr Mol Med 2009; 9:411-6; PMID:19519398; http://dx.doi.org/10.2174/156652409788167096.
39. Colombo SL, Palacios-Callender M, Frakich N, Carcamo S, Kovacs I, Tudzarova S, et al. Molecular basis for the differential use of glucose and glutamine in cell proliferation as revealed by synchronized HeLa cells. Proc Natl Acad Sci USA 2011; 108:21069-74; PMID:22106309; http://dx.doi.org/10.1073/ pnas.1117500108.
40. Massagué J. TGF-beta signal transduction. Annu Rev Biochem 1998; 67:753-91; PMID:9759503; http://dx.doi.org/10.1146/annurev.biochem.67.1.753.
41. Lefkimmiatis K, Caratozzolo MF, Merlo P, D'Erchia AM, Navarro B, Levrero M, et al. p73 and p63 sustain cellular growth by transcriptional activation of cell cycle progression genes. Cancer Res 2009; 69:8563-71; PMID:19861536; http://dx.doi.org/10.1158/0008-5472.CAN-09-0259.
42. Cigognini D, Corneo G, Fermo E, Zanella A, Tripputi P. HIC gene, a candidate suppressor gene within a minimal region of loss at 7q31.1 in myeloid neoplasms. Leuk Res 2007; 31:477-82; PMID:17064770; http://dx.doi.org/10.1016/j. leukres.2006.09.007.
43. Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science 2011; 334:1081-6; PMID:22116877; http://dx.doi.org/10.1126/science.1209038.